Skopos Labs Inc. Makes New Investment in Johnson & Johnson (NYSE:JNJ)

Skopos Labs Inc. bought a new position in Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 14,566 shares of the company’s stock, valued at approximately $2,283,000. Johnson & Johnson comprises approximately 1.1% of Skopos […]

Related Keywords

United States ,California ,America , ,California Public Employees Retirement System ,Cantor Fitzgerald ,Clearbridge Investments ,Exchange Commission ,Johnson Company Profile ,Skopos Labs Inc ,Dimensional Fund Advisors ,Morgan Stanley ,Charles Schwab Investment Management Inc ,Norges Bank ,Johnson ,Skopos Labs ,Free Report ,Schwab Investment Management ,Public Employees Retirement System ,Fund Advisors ,Get Free Report ,Innovative Medicine ,Visit Holdingschannel ,Johnson Daily ,